Oscar Health president sells over $115k in company stock By Investing.com

Oscar Health, Inc. (NYSE:OSCR) reported that its President of Technology and Chief Technology Officer, Mario Schlosser, has recently sold shares of the company’s stock. According to the latest SEC filing, Schlosser sold a total of 5,960 shares of Class A Common Stock in two separate transactions.

On June 3, 2024, Schlosser sold 5,808 shares at a weighted average price of $19.46, resulting in a transaction value of approximately $113,000. The prices for these shares ranged from $19.01 to $19.82. Following this sale, Schlosser continued the sell-off on June 4, 2024, with 152 shares disposed of at a weighted average price of $19.09, totaling around $2,900. The shares on this date were sold at prices between $19.01 and $19.10.

These sales were executed in accordance with a Rule 10b5-1 instruction letter, which Schlosser had entered into well before the transactions took place, specifically to satisfy his tax withholding obligations upon the vesting of previously granted equity awards.

Investors may note that the sales occurred shortly after Schlosser exercised his options for 14,411 restricted stock units on June 1, 2024. These units are set to vest over a three-year period in 12 equal quarterly installments starting from June 1, 2024. Each restricted stock unit represents a contingent right to receive one share of Class A common stock, and as a result of this exercise, Schlosser’s total ownership in non-derivative securities increased.

Following these transactions, Schlosser’s direct ownership in Oscar Health’s Class A Common Stock stands at 65,768 shares. Additionally, he holds 158,529 restricted stock units in derivative securities.

Oscar Health, Inc., based in New York, operates within the hospital and medical service plans industry and is known for its innovative approach to health insurance. The company’s recent transactions are part of the regular financial disclosures required of its executives.

InvestingPro Insights

Oscar Health, Inc. (NYSE:OSCR) has been in the spotlight recently due to its executive stock transactions, but there’s more to the company’s financial narrative. According to InvestingPro data, Oscar Health has a market capitalization of $4.48 billion, highlighting its substantial size within the hospital and medical service plans industry. Despite a challenging gross profit margin of 21.87% in the last twelve months as of Q1 2024, the company has experienced impressive revenue growth of 45.77% during the same period.

Investors might be intrigued by the company’s stock price movements, which have been notably volatile. The InvestingPro Tips suggest that while Oscar Health is not currently profitable, with a P/E Ratio of -79.75, it has had a strong return over the last three months, with a 23.45% price total return. Moreover, over the past six months, the stock has seen a substantial price uptick, with a 128.31% return.

While the company does not pay dividends, the high Price / Book multiple of 4.41 could suggest that investors are expecting future growth, particularly since analysts predict the company will be profitable this year. This optimism is further supported by the company’s net income, which is also expected to grow.

For readers looking to delve deeper into Oscar Health’s financials and future prospects, there are additional InvestingPro Tips available at: https://www.investing.com/pro/OSCR. These tips could provide valuable insights, especially when considering the recent insider transactions. Furthermore, you can use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, offering access to a wealth of financial analysis and data to inform your investment decisions. With 9 more InvestingPro Tips listed in InvestingPro, investors have a rich resource to explore Oscar Health’s potential in the market.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.